Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 341

1.

Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.

D'Ascenzo F, Bertaina M, Fioravanti F, Bongiovanni F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Blanco PF, Garay A, Quadri G, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Rinaldi M, Lüscher TF.

Eur J Prev Cardiol. 2019 Mar 12:2047487319836327. doi: 10.1177/2047487319836327. [Epub ahead of print]

PMID:
30862233
2.

Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.

Ikonomidis I, Pavlidis G, Katsimbri P, Andreadou I, Triantafyllidi H, Tsoumani M, Varoudi M, Vlastos D, Makavos G, Kostelli G, Βenas D, Lekakis J, Parissis J, Boumpas D, Alexopoulos D, Iliodromitis E.

Clin Res Cardiol. 2019 Mar 11. doi: 10.1007/s00392-019-01443-9. [Epub ahead of print]

PMID:
30859382
3.

Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner?

Mantis C, Alexopoulos D.

Thromb Res. 2019 Feb 22;176:133-139. doi: 10.1016/j.thromres.2019.02.022. [Epub ahead of print]

PMID:
30826397
4.

De-Escalation of Treatment With Oral P2Y12 Receptor Inhibitors: Current Status and Perspectives.

Alexopoulos D, Lianos I, Vlachakis P, Sfantou D, Dragona VM, Varlamos C.

J Cardiovasc Pharmacol Ther. 2019 Feb 5:1074248418823724. doi: 10.1177/1074248418823724. [Epub ahead of print]

PMID:
30722685
5.

Platelet inhibition with standard versus lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study.

Kubica J, Adamski P, Buszko K, Baranska M, Sikora J, Piotr Marszall M, Sobczak P, Sikora A, Kuliczkowski W, Fabiszak T, Kubica A, Jilma B, Alexopoulos D, Navarese EP.

Eur Heart J Cardiovasc Pharmacother. 2019 Jan 23. doi: 10.1093/ehjcvp/pvz004. [Epub ahead of print]

PMID:
30689800
6.

Increase in Carotid Temperature Heterogeneity Is Associated With Cardiovascular and Cerebrovascular Events.

Toutouzas K, Benetos G, Oikonomou G, Barampoutis N, Koutagiar I, Galanakos S, Karmpalioti M, Drakopoulou M, Stathogiannis K, Bounas P, Gata V, Antoniadou F, Davlouros P, Alexopoulos D, Hahalis G, Siores E, Sfikakis PP, Tousoulis D.

Circ Cardiovasc Imaging. 2018 Nov;11(11):e008292. doi: 10.1161/CIRCIMAGING.118.008292. No abstract available.

PMID:
30571323
7.

Prenatal to postnatal trajectory of brain growth in complex congenital heart disease.

Ortinau CM, Mangin-Heimos K, Moen J, Alexopoulos D, Inder TE, Gholipour A, Shimony JS, Eghtesady P, Schlaggar BL, Smyser CD.

Neuroimage Clin. 2018;20:913-922. doi: 10.1016/j.nicl.2018.09.029. Epub 2018 Sep 27.

8.

Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI.

Conrotto F, Bertaina M, Raposeiras-Roubin S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Quadri G, Varbella F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Abu-Assi E, D'Ascenzo F.

Eur Heart J Acute Cardiovasc Care. 2018 Oct 1:2048872618802783. doi: 10.1177/2048872618802783. [Epub ahead of print]

PMID:
30270638
9.

Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

Alexopoulos D, Pappas C, Sfantou D, Xanthopoulou I, Didagelos M, Kikas P, Ziakas A, Tziakas D, Karvounis H, Iliodromitis E.

J Am Coll Cardiol. 2018 Oct 2;72(14):1750-1751. doi: 10.1016/j.jacc.2018.07.041. No abstract available.

PMID:
30261967
10.

Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry.

D'Ascenzo F, Grosso A, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Ali HH, Magnani G, Autelli M, Blanco PF, Garay A, Quadri G, Marra WG, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Raposeiras-Roubin S.

Int J Cardiol. 2018 Dec 15;273:29-33. doi: 10.1016/j.ijcard.2018.09.020. Epub 2018 Sep 6.

PMID:
30228021
11.

In-Scaffold Neoatherosclerosis: An Overestimated Entity?

Andreou I, Alexopoulos D.

J Am Coll Cardiol. 2018 Aug 28;72(9):1063-1064. doi: 10.1016/j.jacc.2018.05.069. No abstract available.

PMID:
30139436
12.

CYP2C19 Genetic Polymorphism and Pharmacodynamics of Prasugrel Maintenance Dose in Patients Undergoing Percutaneous Coronary Intervention.

Kassimis G, Alexopoulos D.

Cardiology. 2018;140(4):237-238. doi: 10.1159/000492422. Epub 2018 Aug 23. No abstract available.

13.

Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study.

Grodecki K, Huczek Z, Scisło P, Kowara M, Raposeiras-Roubín S, D'Ascenzo F, Abu-Assi E, Henriques JPS, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Opolski G, Filipiak KJ.

Thromb Res. 2018 Aug;168:156-163. doi: 10.1016/j.thromres.2018.06.022. Epub 2018 Jun 28.

PMID:
30064688
14.

Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.

Raposeiras-Roubín S, Caneiro Queija B, D'Ascenzo F, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tomassini F, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Calvo-Iglesias F, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A, Abu-Assi E.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):215-223. doi: 10.1016/j.rec.2018.06.004. Epub 2018 Jul 18. English, Spanish.

PMID:
30029980
15.

Does Ticagrelor Improve Endothelial Function?

Moulias A, Xanthopoulou I, Alexopoulos D.

J Cardiovasc Pharmacol Ther. 2019 Jan;24(1):11-17. doi: 10.1177/1074248418786936. Epub 2018 Jul 10.

PMID:
29991269
16.

Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.

Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Fernández-Barbeira S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tommassini F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):298-304. doi: 10.1016/j.rec.2018.05.021. Epub 2018 Jun 25. English, Spanish.

PMID:
29954720
17.

Aspirin hypersensitivity in patients undergoing percutaneous coronary intervention. What should we be doing?

Kassimis G, Raina T, Alexopoulos D.

Curr Vasc Pharmacol. 2018 Jun 3. doi: 10.2174/1570161116666180604100220. [Epub ahead of print]

PMID:
29866010
18.

Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.

Alexopoulos D, Xenogiannis I, Vlachakis P, Tantry U, Gurbel PA.

Thromb Haemost. 2018 Jul;118(7):1131-1140. doi: 10.1055/s-0038-1649484. Epub 2018 Jun 4.

PMID:
29864784
19.

Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry.

Guerrero C, Garay A, Ariza-Solé A, Formiga F, Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Kinnaird T, Manzano-Fernández S, Alegre O, Sánchez-Salado JC, Lorente V, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Conrotto F, Bertaina M, Autelli M, Grosso A, Blanco PF, Quadri G, Varbella F, Tomassini F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Alexopoulos D, Iñiguez-Romo A, Gaita F, Cequier Á.

Thromb Res. 2018 May 22;167:142-148. doi: 10.1016/j.thromres.2018.05.024. [Epub ahead of print]

PMID:
29857270
20.

Ticagrelor Versus Clopidogrel as Part of Dual or Triple Antithrombotic Therapy: a Systematic Review and Meta-Analysis.

Andreou I, Briasoulis A, Pappas C, Ikonomidis I, Alexopoulos D.

Cardiovasc Drugs Ther. 2018 Jun;32(3):287-294. doi: 10.1007/s10557-018-6795-9.

PMID:
29766335

Supplemental Content

Loading ...
Support Center